Related Experiment Videos
Expression of CYP2A genes in human liver and extrahepatic tissues
S Koskela1, J Hakkola, J Hukkanen
1Department of Pharmacology and Toxicology, University of Oulu, Finland.
Abstract:
Members of the human cytochrome P450 2A (CYP2A) subfamily are known to metabolize several promutagens, procarcinogens, and pharmaceuticals. In this study, the expression of the three genes found in the human CYP2A gene cluster was investigated in the liver and several extrahepatic tissues by gene-specific reverse transcriptase-polymerase chain reaction (RT-PCR). All three transcripts (CYP2A6, CYP2A7, and CYP2A13) were found to be present in liver. Quantitative RT-PCR analysis showed that CYP2A6 and CYP2A7 mRNAs were present at roughly equal levels in the liver, while CYP2A13 was expressed at very low levels. Two putative splicing variants of CYP2A7 were found in the liver. Nasal mucosa contained a low level of CYP2A6 and a relatively high level of CYP2A13 transcripts. Kidney, duodenum, lung, alveolar macrophages, peripheral lymphocytes, placenta, and uterine endometrium were negative for all transcripts. This survey gives a comprehensive picture of the expression pattern of CYP2A genes in liver and extrahepatic tissues and constitutes a basis for a search for functional CYP2A forms and their roles in chemical toxicity in liver and nasal mucosa.
Insights
This study maps human cytochrome P450 2A (CYP2A) gene expression in various tissues. CYP2A6, CYP2A7, and CYP2A13 genes are expressed in the liver, with CYP2A13 also found in nasal mucosa.
Area of Science:
- Pharmacogenomics
- Molecular biology
- Toxicology
Background:
- The human cytochrome P450 2A (CYP2A) subfamily plays a crucial role in metabolizing various xenobiotics, including promutagens, procarcinogens, and pharmaceuticals.
- Understanding the tissue-specific expression of CYP2A genes is vital for assessing chemical toxicity and drug metabolism.
- Previous knowledge on the expression patterns of all three human CYP2A genes (CYP2A6, CYP2A7, and CYP2A13) across multiple tissues is limited.
Purpose of the Study:
- To comprehensively investigate and map the expression patterns of the three human CYP2A genes (CYP2A6, CYP2A7, and CYP2A13) in the liver and various extrahepatic tissues.
- To identify tissues where specific CYP2A isoforms are expressed, laying the groundwork for functional studies.
- To provide a basis for understanding the role of CYP2A enzymes in chemical toxicity, particularly in the liver and nasal mucosa.
Main Methods:
- Gene-specific reverse transcriptase-polymerase chain reaction (RT-PCR) was employed to detect and quantify CYP2A gene transcripts.
- Quantitative RT-PCR was utilized to determine the relative mRNA levels of CYP2A6, CYP2A7, and CYP2A13 in the liver.
- A range of human tissues, including liver, nasal mucosa, kidney, duodenum, lung, and blood cells, were analyzed for CYP2A gene expression.
Main Results:
- All three CYP2A transcripts (CYP2A6, CYP2A7, and CYP2A13) were detected in the human liver.
- CYP2A6 and CYP2A7 mRNA were found at comparable levels in the liver, whereas CYP2A13 expression was significantly lower.
- Nasal mucosa showed low levels of CYP2A6 and relatively high levels of CYP2A13 transcripts; other tested tissues were negative for all CYP2A genes.
Conclusions:
- This study provides a detailed expression profile of human CYP2A genes in the liver and key extrahepatic tissues.
- The findings highlight the liver and nasal mucosa as primary sites for CYP2A gene expression, suggesting their potential roles in local chemical metabolism and toxicity.
- The comprehensive expression data serves as a foundation for future research into the functional significance of CYP2A enzymes in xenobiotic metabolism and disease.